Healthcare -
Biotechnology - NASDAQ - US
$ 59.76
1.03 %
$ 7.36 B
Market Cap
17.42
P/E
HALO - FREE CASH FLOW
Free Cash Flow HALO - Halozyme Therapeutics, Inc.
468 M
LAST VALUE
41.09%
2 YEAR CAGR
48.56%
5 YEAR CAGR
27.75%
10 YEAR CAGR